Loading

logo

Journal of Cellular Immunology

ISSN: 2689-2812

Commentary Open Access
Volume 3 | Issue 3 | DOI: https://doi.org/10.33696/immunology.3.099

The Potential of Combination Therapies and Patient Stratification to Improve CCR2 Inhibition Therapeutics

Jason E. Duex1, Dan Theodorescu1,2,*
  • 1Department of Surgery (Urology), Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • 2Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA
+ Affiliations - Affiliations

Corresponding Author

Dan Theodorescu, dan.theodorescu@cshs.org

Received Date: April 11, 2021

Accepted Date: June 14, 2021

Citation:

Duex JE, Theodorescu D. The Potential of Combination Therapies and Patient Stratification to Improve CCR2 Inhibition Therapeutics. J Cell Immunol. 2021; 3(3): 198-200.


Copyright: © 2021 Duex JE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Keywords

Bladder cancer, Tumor progression, PD-1, PD-L1, Cytokines, Checkpoint inhibitors, Immunotherapy, CCL2, CCR2

Recommended Articles

Full Text
Cite
Download PDF
Author Information X

About Scientific Archives

Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.

Read More